32 – 33 The variables nominally associated with the MAPK14 variants within the dyslipidemia subgroup need to be interpreted with caution due to the modest significance levels and small number of carriers, but are provided for descriptive purposes.
← all excerpts
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
1
—
—